Expiratory muscle strength as a predictor of functional exercise capacity in generalized myasthenia gravis

References

1. ↵
   1. Querol L,
   2. Illa I

   (2013) Myasthenia gravis and the neuromuscular junction. Curr Opin Neurol 26, 459–465.
2. ↵
   1. Gilhus NE,
   2. Nacu A,
   3. Andersen JB,
   4. Owe JF

   (2015) Myasthenia gravis and risks for comorbidity. Eur J Neurol 22, 17–23.
3. ↵
   1. Keenan SP,
   2. Alexander D,
   3. Road JD,
   4. Ryan CF,
   5. Oger J,
   6. Wilcox PG

   (1995) Ventilatory muscle strength and endurance in myasthenia gravis. Eur Respir J 8, 1130–1135.
4. 1. Mier-Jedrzejowicz AK,
   2. Brophy C,
   3. Green M

   (1988) Respiratory muscle function in myasthenia gravis. Am Rev Respir Dis 138, 867–873.
5. ↵
   1. Oliveira EF,
   2. Nacif SR,
   3. Fonseca NT,
   4. Apostólico N,
   5. Urbano JJ,
   6. Guimarães LL,
   7. et al.

   (2014) Pulmonary function and respiratory muscle strength in myasthenia gravis. Man Ther Posturology Rehabil 12, 252–259.
6. ↵
   1. Saraiva PA,
   2. de Assis JL,
   3. Marchiori PE

   (1996) Evaluation of the respiratory function in myasthenia gravis. An important tool for clinical feature and diagnosis of the disease. Arq Neuropsiquiatr 54, 601–607.
7. ↵
   1. Heliopoulos I,
   2. Patlakas G,
   3. Vadikolias K,
   4. Artemis N,
   5. Kleopa KA,
   6. Maltezos E,
   7. et al.

   (2003) Maximal voluntary ventilation in myasthenia gravis. Muscle Nerve 27, 715–719.
8. ↵
   1. Jordan B,
   2. Mehl T,
   3. Schweden TLK,
   4. Menge U,
   5. Zierz S

   (2017) Assessment of physical fatigability and fatigue perception in myasthenia gravis. Muscle Nerve 55, 657–663.
9. ↵
   1. Knak KL,
   2. Andersen LK,
   3. Witting N,
   4. Vissing J

   (2017) Reliability of the 2- and 6-minute walk tests in neuromuscular diseases. J Rehabil Med 49, 362–366.
10. ↵
    1. Burns TM,
    2. Conaway M,
    3. Sanders DB

    (2010) The MG Composite:A valid and reliable outcome measure for myasthenia gravis. Neurology 74, 1434–1440.
11. ↵
    1. Miller MR,
    2. Crapo R,
    3. Hankinson J,
    4. Brusasco V,
    5. Burgos F,
    6. Casaburi R,
    7. et al.

    (2005) General considerations for lung function testing. Eur Respir J 26, 153–161.
12. ↵
    1. American Thoracic Society/European Respiratory Society ATS/ERS Statement on respiratory muscle testing

    (2002) Am J Respir Crit Care Med 166, 518–624.
13. ↵
    1. Evans JA,
    2. Whitelaw WA

    (2009) The assessment of maximal respiratory mouth pressures in adults. Respir Care 54, 1348–1359.
14. ↵
    1. Troosters T,
    2. Gosselink R,
    3. Decramer M

    (2005) Respiratory muscle assessment. Eur Respir Mon 31, 57–71.
15. ↵
    1. Goksen S

    (2014) Assessment of respiratory muscle endurance in chronic obstructive pulmonary disease (Hacettepe University Institute of Health Sciences Master Thesis, Ankara).
16. ↵
    1. Holland AE,
    2. Spruit MA,
    3. Troosters T,
    4. Puhan MA,
    5. Pepin V,
    6. Saey D,
    7. et al.

    (2014) An official European Respiratory Society/American Thoracic Society technical standard:field walking tests in chronic respiratory disease. Eur Respir J 44, 1428–1446.
17. ↵
    1. Enright PL,
    2. Sherrill DL

    (1998) Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158, 1384–1387.
18. ↵
    1. Hayran M,
    2. Hayran M

    , eds (2011) Sağlık Araştırmalarıİçin Temel İstatistik (Omega Yayınları, Ankara).
19. ↵
    1. Domholdt E

    , ed (2000) Physical Therapy Research: Principles and Applications (WB Saunders, Philadelphia (PA)).
20. ↵
    1. Heinze G,
    2. Wallisch C,
    3. Dunkler D

    (2018) Variable selection - A review and recommendations for the practicing statistician. Biom J 60, 431–449.
21. ↵
    1. Faul F,
    2. Erdfelder E,
    3. Lang AG,
    4. Buchner A

    (2007) G*Power 3:a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39, 175–191.
22. ↵
    1. Gibbons WJ,
    2. Fruchter N,
    3. Sloan S,
    4. Levy RD

    (2001) Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 21, 87–93.
23. ↵
    1. Elsais A,
    2. Johansen B,
    3. Kerty E

    (2010) Airway limitation and exercise intolerance in well-regulated myasthenia gravis patients. Acta Neurol Scand Suppl, 12–17.
24. ↵
    1. Ringqvist I,
    2. Ringqvist T

    (1971) Respiratory mechanics in untreated myasthenia gravis with special reference to the respiratory forces. Acta Med Scand 190, 499–508.
25. ↵
    1. Osserman KE,
    2. Genkins G

    (1971) Studies in myasthenia gravis:review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 38, 497–537.
26. ↵
    1. Cejvanovic S,
    2. Vissing J

    (2014) Muscle strength in myasthenia gravis. Acta Neurol Scand 129, 367–373.
27. ↵
    1. Citirak G,
    2. Cejvanovic S,
    3. Andersen H,
    4. Vissing J

    (2016) Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis. PLoS One 11, e0164092.
28. (2002) ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement:guidelines for the six-minute walk test. Am J Respir Crit Care Med 166, 111–117.
29. ↵
    1. Singh SJ,
    2. Puhan MA,
    3. Andrianopoulos V,
    4. Hernandes NA,
    5. Mitchell KE,
    6. Hill CJ,
    7. et al.

    (2014) An official systematic review of the European Respiratory Society/American Thoracic Society:measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 44, 1447–1478.
30. ↵
    1. Kluger BM,
    2. Krupp LB,
    3. Enoka RM

    (2013) Fatigue and fatigability in neurologic illnesses:proposal for a unified taxonomy. Neurology 80, 409–416.
31. ↵
    1. Elsais A,
    2. Wyller VB,
    3. Loge JH,
    4. Kerty E

    (2013) Fatigue in myasthenia gravis:is it more than muscular weakness? BMC Neurol 13, 132.
32. ↵
    1. Singer J,
    2. Yelin EH,
    3. Katz PP,
    4. Sanchez G,
    5. Iribarren C,
    6. Eisner MD,
    7. et al.

    (2011) Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease:impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 31, 111–119.
33. ↵
    1. Gosselink R,
    2. Troosters T,
    3. Decramer M

    (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153, 976–980.